Reactive oxygen species (ROS) are crucial molecules in cancer therapy. Unfortunately, the therapeutic efficiency of ROS is unsatisfactory in clinic, primarily due to their rigorous production conditions. By taking advantage of the intrinsic acidity and overproduction of H 2 O 2 in the tumor environment, we have reported an ROS nanoreactor based on core−shell-structured iron carbide (Fe 5 C 2 @Fe 3 O 4 ) nanoparticles (NPs) through the catalysis of the Fenton reaction. These NPs are able to release ferrous ions in acidic environments to disproportionate H 2 O 2 into • OH radicals, which effectively inhibits the proliferation of tumor cells both in vitro and in vivo. The high magnetization of Fe 5 C 2 @Fe 3 O 4 NPs is favorable for both magnetic targeting and T 2 -weighted magnetic resonance imaging (MRI). Ionization of these NPs simultaneously decreases the T 2 signal and enhances the T 1 signal in MRI, and this T 2 /T 1 switching process provides the visualization of ferrous ions release and ROS generation for the supervision of tumor curing. These Fe 5 C 2 @Fe 3 O 4 NPs show great potential in endogenous environment-excited cancer therapy with high efficiency and tumor specificity and can be guided further by MRI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.